ArriVent BioPharma, Inc. (AVBP)

NASDAQ

$16.26

$+0.12

(+0.75%)

Previous Close: ⁦$16.09⁩

Market Closed

ArriVent BioPharma, Inc. (AVBP) Live Price Chart

Last updated: ⁦2026-10-15 04:36:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

ArriVent BioPharma, Inc. (AVBP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.26, with a market capitalization of $811.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.36 to $35.83. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$811.61M
Open	$16.06
Day's High	$36.37
Day's Low	$11.36
Previous Close	$16.09
Volume	1.40M
Average Volume	981.40K
P/E Ratio	--
52-Week High	$35.83
52-Week Low	$11.36
Dividend Yield	--
Earnings Date	--

ArriVent BioPharma, Inc. (AVBP) Latest Closing Stock Price

ArriVent BioPharma, Inc. (AVBP) last closed at $16.09 as of 2026-10-14 23:31:00, unchanged from the previous close of $16.09.

During the latest regular trading session, AVBP traded between $11.36 and $36.37, with a volume of 1.40M shares. The closing price was near the lower end and near the lower end of its 52-week range.

ArriVent BioPharma, Inc. (AVBP) 7-Day Stock Price Change

Over the past seven days, ArriVent BioPharma, Inc. (AVBP) moved from $28.46 to $16.26, representing a decline of 42.85% ($12.20).

The stock traded between $11.36 and $28.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 4.54 million shares, up versus the previous seven-day period, indicating higher trading activity.

AVBP 52-Week Price Position

Position in Range: 20.0%

52W Low$11.36

52W High$35.83

AVBP is currently trading at $16.26, placing it 20.0% of the way from its 52-week low of $11.36 to its 52-week high of $35.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ArriVent BioPharma, Inc. (AVBP)?

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.

ArriVent BioPharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	77
Exchange	NASDAQ
Company Website	https://www.arrivent.com

How to Buy ArriVent BioPharma, Inc. (AVBP) Stock on MEXC

Eligible investors can buy real shares of ArriVent BioPharma, Inc. (AVBP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVBP and Place Your Order

Open the RealStocks trading page and search for AVBP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ArriVent BioPharma, Inc. (AVBP) stock price today?

ArriVent BioPharma, Inc. (AVBP) is currently trading at $ 16.26, up 1.08% ($0.17) from the previous close of $ 16.09. Intraday prices update in real time during regular trading hours.

2.Is AVBP stock going up or down today?

As of 2026-10-14 23:31:00, AVBP is trading at $ 16.26, up 1.08% ($0.17) from its previous close of $ 16.09. The stock has traded between $ 11.36 and $ 36.37 during today’s regular session. Past price movements do not guarantee future results.

3.What is AVBP pre-market price?

As of 2026-10-14 23:31:00, AVBP is trading at $ 15.77 in pre-market trading, down 2.02% ($0.32) from the previous close of $ 16.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVBP after-hours price?

As of 2026-10-14 23:31:00, AVBP is trading at $ 16.02 in after-hours trading, down 0.44% ($0.07) from the regular-session close of $ 16.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVBP stock trading now?

AVBP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVBP sit relative to its 52-week high and low?

Over the past 52 weeks, AVBP has traded between a low of $ 11.36 and a high of $ 35.83. At $ 16.26, the stock is positioned 20.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ArriVent BioPharma, Inc. in?

ArriVent BioPharma, Inc. (AVBP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ArriVent BioPharma, Inc.'s market capitalization and where is it listed?

ArriVent BioPharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 811.61M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVBP valued in terms of P/E ratio and EPS?

AVBP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.32. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ArriVent BioPharma, Inc. pay a dividend?

ArriVent BioPharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.